Gastrin I en es it fr

Gastrin I Brand names, Gastrin I Analogs

Gastrin I Brand Names Mixture

  • No information avaliable

Gastrin I Chemical_Formula

C21H26NO3

Gastrin I RX_link

No information avaliable

Gastrin I fda sheet

Gastrin I msds (material safety sheet)

Gastrin I Synthesis Reference

No information avaliable

Gastrin I Molecular Weight

340.436 g/mol

Gastrin I Melting Point

No information avaliable

Gastrin I H2O Solubility

No information avaliable

Gastrin I State

Solid

Gastrin I LogP

No information avaliable

Gastrin I Dosage Forms

Tablet (50 mg)

Gastrin I Indication

For the treatment of peptic ulcer disease, irritable bowel syndrome, pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, and reflex neurogenic bladder in children.

Gastrin I Pharmacology

Methantheline is a synthetic quarternary ammonium antimuscarinic used to relieve cramps or spasms of the stomach, intestines, and bladder. It can be used together with antacids or other medicines, such as H2-receptor antagonists, in the treatment of peptic ulcer. Methantheline inhibits muscarinic actions at postganglionic parasympathetic neuroeffector sites.

Gastrin I Absorption

Rapidly absorbed.

Gastrin I side effects and Toxicity

Symptoms of overdose: blurred vision (continuing) or changes in near vision, clumsiness or unsteadiness, confusion, convulsions, difficulty in breathing, muscle weakness (severe), or tiredness (severe), dizziness, drowsiness (severe), dryness of mouth, nose, or throat (severe), fast heartbeat, fever, hallucinations, slurred speech, unusual excitement, nervousness, restlessness, or irritability, unusual warmth, dryness, and flushing of skin.

Gastrin I Patient Information

No information avaliable

Gastrin I Organisms Affected

Humans and other mammals